BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-1.13%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.86B
AUM Growth
+$5.86B
(+222%)
Cap. Flow
+$4.03B
Cap. Flow
% of AUM
68.76%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
219
New
83
Increased
86
Reduced
22
Closed
16
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$492M |
| 2 |
Incyte
INCY
|
$310M |
| 3 |
Neurocrine Biosciences
NBIX
|
$298M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$239M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$239M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$29.2M |
| 2 |
Cencora
COR
|
$19.9M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$16.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$14.7M |
| 5 |
Illumina
ILMN
|
$10.9M |
Sector Composition
| 1 | Healthcare | 94.72% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.42% |
| 4 | Financials | 0.06% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
101
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.46M | 0.11% | 268,500 +109,700 | +69% | +$2.64M |
|
102
ResMed
RMD
$40.2B
| $6.42M | 0.11% | 52,626 -2,041 | -4% | -$249K |
|
|
VCRA
103
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.18M | 0.11% | 193,634 +35,420 | +22% | +$1.13M |
|
|
SILK
104
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.15M | 0.1% | +126,810 | New | +$6.15M |
|
|
SWAV
105
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.57M | 0.1% | 97,547 -2,453 | -2% | -$140K |
|
|
AGN
106
DELISTED
Allergan plc
AGN
| $5.38M | 0.09% | +32,100 | New | +$5.38M |
|
|
SGEN
107
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.05M | 0.09% | 73,000 +27,200 | +59% | +$1.88M |
|
|
MTLS
108
Materialise
MTLS
$302M
| $4.7M | 0.08% | 240,770 -27,639 | -10% | -$540K |
|
109
Neuronetics
STIM
$220M
| $4.06M | 0.07% | 324,779 +29,442 | +10% | +$368K |
|
110
Henry Schein
HSIC
$8.44B
| $4.05M | 0.07% | 57,917 +7,255 | +14% | +$507K |
|
111
Penumbra
PEN
$10.6B
| $4.03M | 0.07% | 25,180 +1,543 | +7% | +$247K |
|
112
Cidara Therapeutics
CDTX
$1.66B
| $3.86M | 0.07% | +2,295,272 | New | +$3.86M |
|
113
Agilent Technologies
A
$35.7B
| $3.79M | 0.06% | +50,782 | New | +$3.79M |
|
114
PTC Therapeutics
PTCT
$3.92B
| $3.76M | 0.06% | 83,500 +48,800 | +141% | +$2.2M |
|
115
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.68M | 0.06% | 166,635 -150,500 | -47% | -$3.33M |
|
116
Avantor
AVTR
$9.18B
| $3.57M | 0.06% | +187,231 | New | +$3.57M |
|
117
Zai Lab
ZLAB
$3.68B
| $3.49M | 0.06% | 100,000 +70,000 | +233% | +$2.44M |
|
118
CVS Health
CVS
$92.8B
| $3.23M | 0.06% | 59,326 +1,699 | +3% | +$92.6K |
|
|
SYNH
119
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.17M | 0.05% | 62,000 +14,800 | +31% | +$756K |
|
120
Kura Oncology
KURA
$686M
| $2.86M | 0.05% | 145,200 +115,900 | +396% | +$2.28M |
|
121
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.78M | 0.05% | 103,800 | – | – |
|
|
ARNA
122
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.75M | 0.05% | 46,917 | – | – |
|
|
CSLT
123
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.58M | 0.04% | 800,000 -1,020,470 | -56% | -$3.3M |
|
|
BNFT
124
DELISTED
Benefitfocus, Inc.
BNFT
| $2.39M | 0.04% | 88,163 +65,184 | +284% | +$1.77M |
|
|
BLUE
125
DELISTED
bluebird bio
BLUE
| $2.32M | 0.04% | 18,200 -4,900 | -21% | -$623K |
|